Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors ... About 23% of Oura members ...

and commercializing continuous glucose monitoring (CGM) systems. Its products, including the Dexcom G6 and G7, aim to help people with diabetes manage their blood glucose levels through real-time data ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by astronauts ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

DexCom is a pioneer in the development of continuous glucose monitoring (CGM) systems, which are used by people managing diabetes. Its innovative devices like the G6 and G7 have set the standard ...

Personal stories of people using one CGM system or another are only anecdotal ... has to pay for FreeStyle Libre - in comparison to Dexcom's G6 (or G7) and also in comparison to Medtronic's ...

StockNews.com lowered shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a research report report published on Saturday. A number of other analysts have also weighed in ...

This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...